Company
Pinetree Therapeutics
| Industry | preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Pinetree Therapeutics | Series B | 2025-10-29 |
Company
| Industry | preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers |
|---|
| Company | Round | Date |
|---|---|---|
| Pinetree Therapeutics | Series B | 2025-10-29 |